Dr. Reddy's Laboratories
RDY
#2050
Rank
S$12.69 B
Marketcap
S$15.24
Share price
3.69%
Change (1 day)
-17.73%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2026 (TTM): S$0.85 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are S$3.76 Billion. In 2025 the company made an earning of S$1.12 Billion a decrease over its 2024 earnings that were of S$1.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.85 B-24.62%
2025 S$1.12 B-2.73%
2024 S$1.15 B7.01%
2023 S$1.08 B32.93%
2022 S$0.81 B26.77%
2021 S$0.64 B31.44%
2020 S$0.48 B54.54%
2019 S$0.31 B-14.21%
2018 S$0.36 B26.41%
2017 S$0.29 B4.47%
2016 S$0.27 B-55.7%
2015 S$0.63 B1.83%
2014 S$0.61 B-3.78%
2013 S$0.64 B54.07%
2012 S$0.41 B-16.23%
2011 S$0.49 B56.66%
2010 S$0.31 B-235.36%
2009 -S$0.24 Billion-198.53%
2008 S$0.23 B30.77%
2007 S$0.18 B-14.61%
2006 S$0.21 B703.63%
2005 S$26.61 M649.45%
2004 S$3.55 M-95.68%
2003 S$82.1 M-14.86%
2002 S$96.43 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$20.39 B 2,278.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.68 B 1,495.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.89 B 1,053.88%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
S$12.93 B 1,408.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$2.93 B 242.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel